Cart summary

You have no items in your shopping cart.

Ursodeoxycholic acid

SKU: orb1226618

Description

Ursodiol reduces cholesterol absorption and is used to dissolve gallstones.(In Vitro):Ursodeoxycholic acid (10 μM; 24 h) reduces ACE2 and SHP levels in primary airway and intestinal organoids, and reduces SARS-CoV-2 infection in multiple cell types via FXR-mediated ACE2 regulation.\n(In Vivo):Ursodeoxycholic acid (50, 150, and 450 mg/kg; p.o.; daily for 21 days) results in weight loss in C57BL/6J wildtype mice.Ursodeoxycholic acid (1% w/w or 416 mg/kg; oral; 7 days) reduces ACE2 expression in mice and hamsters.Ursodeoxycholic acid (416 mg/kg; oral; 7 days) reduces SARS-CoV-2 infection in hamsters.

Images & Validation

Key Properties

CAS Number128-13-2
MW392.57
Purity>98% (HPLC)
FormulaC24H40O4
SMILESC[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C
TargetPotassium Channel
SolubilityEthanol: 79 mg/mL (201.23 mM); DMSO: 79 mg/mL (201.23 mM)

Bioactivity

In Vivo
Animal model: 5 week old C57BL/6J WT mice (male and female). Dosage: 50, 150, and 450 mg/kg dissolved in corn oil. Administration: Oral gavage; daily for 21 days. Result: Mice in the 50 and 450 mg/kg groups sustained significant weight loss within a week. At 50 mg/kg, this weight loss persisted over the course of the experiment. At 450 mg/kg, initially weight loss was noted during the first and third week of ursodiol administration. At 150 mg/kg, it did not have significantly different weights compared to the untreated mice. Animal model: FVB/N mice and Syrian Golden Hamsters. Dosage: 1% w/w for mice, 416 mg/kg for hamsters. Administration: In chow or oral gavage, 7 days. Result: Reduced ACE2 expression. Animal model: Syrian Golden Hamsters, SARS-CoV-2 infection model. Dosage: 416 mg/kg. Administration: Oral gavage, 7 days. Result: Prevented transmission of SARS-CoV-2 in n = 6 out of 9 sentinel animals (33% infected vs. 67% uninfected).

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Ursodeoxycholic acid [orb703039]

    98.0%(HPLC)

    128-13-2

    20 mg
  • NCX 1000 [orb1706122]

    401519-96-8

    685.84

    C38H55NO10

    50 mg, 100 mg, 25 mg
  • Ursodeoxycholic Acid-d4 [orb2280703]

    99.75%

    347841-46-7

    396.6

    C24H40O4

    5 mg, 1 mg, 50 mg, 25 mg, 10 mg
  • Ursodeoxycholic acid sodium [orb1304862]

    99.66%

    2898-95-5

    415.56

    C24H40NaO4

    100 mg
  • Glycochenodeoxycholic Acid [orb1302732]

    99.97%

    640-79-9

    449.62

    C26H43NO5

    10 mg, 50 mg, 100 mg, 200 mg, 500 mg, 25 mg, 5 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Ursodeoxycholic acid (orb1226618)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 g
$ 100.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry